4.5 Article

Screening for VPS35 mutations in Parkinson's disease

Journal

NEUROBIOLOGY OF AGING
Volume 33, Issue 4, Pages -

Publisher

ELSEVIER SCIENCE INC
DOI: 10.1016/j.neurobiolaging.2011.10.032

Keywords

Parkinson's disease; Genetics; VPS35; Population screening

Funding

  1. Wellcome Trust Disease Centre [WT089698/Z/09/Z]
  2. Medical Research Council
  3. Department of Health's National Institute for Health Research Biomedical Research Centres
  4. Medical Research Council [G1100479, MC_G1000735] Funding Source: researchfish
  5. Parkinson's UK [J-0804] Funding Source: researchfish
  6. MRC [G1100479, MC_G1000735] Funding Source: UKRI

Ask authors/readers for more resources

Recently 2 groups have independently identified a mutation in the gene 'vacuolar protein sorting 35 homolog' (VPS35 c.1858G>A; p.Asp620Asn) as a possible cause of autosomal dominant Parkinson's disease (PD). In order to assess the frequency of the reported mutation and to search for other possible disease-causing variants in this gene, we sequenced all 17 exons of VPS35 in 96 familial PD cases, and exon 15 (in which the reported mutation is found) in an additional 64 familial PD cases, 175 young-onset PD cases, and 262 sporadic, neuropathologically confirmed PD cases. We identified 1 individual with the p.Asp620Asn mutation and an autosomal dominant family history of PD. Subsequent follow-up of the family confirmed an affected sibling and cousin who also carried the same mutation. No other potentially disease-causing mutations were identified. We conclude that the VPS35 c.1858G>A mutation is an uncommon cause of familial Parkinson's disease in our population. (C) 2012 Elsevier Inc. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available